High-risk non-metastatic prostate cancer

This Mirrors of Medicine model is designed to get insight into the available evidence on treatment of high-risk non-metastatic prostate cancer, and to learn applying the evidence to decisions in clinical practice. Starting from a specific patient profile, you can see the considerations from an international expert panel, together with an overview of the available evidence and information from international guidelines.

Target audience

Healthcare professionals involved in the management of patients with high-risk non-metastatic prostate cancer (a.o. urologists, radiation oncologists, medical oncologists, and prostate cancer nurses)

Chair

University Hospital Bern, Urology
Bern
Switzerland

Model

Panel

Gustave Roussy Institute, Radiotherapy
Villejuif
France
OLV Hospital, Urology
Aalst
Belgium
Moscow State Medical Stomatological University, Urology
Moscow
Russia
University Hospital Saint-Luc, Urology
Brussels
Belgium
Gustave Roussy Institute, Medical Oncology
Villejuif
France
University Hospital Gasthuisberg, Radiation Oncology
Leuven
Belgium
University Hospital Bern, Urology
Bern
Switzerland
University of Piemonte Orientale, Urology
Novara
Italy
University Hospital Ulm, Radio Oncology
Ulm
Germany